Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Wahana Inti Makmur Tbk. (NASI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Wahana Inti Makmur Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Wahana Inti Makmur Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Wahana Inti Makmur Tbk. trades at Rp165 (market cap 131.61B, 4.22M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5.3× Wahana Inti Makmur Tbk.'s market cap, and Wahana Inti Makmur Tbk. is more actively traded (4.22M versus 635.5K). Which is the better fit depends on your goals.

LABSNASI
Market Cap
691.25B131.61B
Volume
635.5K4.22M
Lot
6.36K42.25K
Turnover
110.15M683.98M
Average Price
173.33161.9
Value
110.15M683.98M
Indicative Equilibrium Price
174165
Indicative Equilibrium Volume
501.61K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
NASI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Wahana Inti Makmur Tbk.

PT Wahana Inti Makmur Tbk (the Company) is established based on Deed of Establishment No. 02 dated February 14, 2015 made by Dr. Tio Jeffrens Maranella, S.H., Notary in Jakarta. The Company started its commercial operations in February 2015.

Read more on NASI